Contraception Advice Relaxed For Mycophenolate In EU, Modified-Release Paracetamol Suspension Confirmed
Executive Summary
The EMA has relaxed its recommendations on the use of contraception in people taking the immunosuppressant, mycophenolate, but continues to stress the importance of avoiding pregnancy in women taking the drug. In another safety-related announcement, EU member states have agreed that products containing modified-release paracetamol should be suspended.